Search Results

You are looking at 1 - 4 of 4 items for :

  • "Xpert MTB/RIF" x
  • All content x
Clear All
European Journal of Microbiology and Immunology
Authors: Kouassi N’Guessan, Timothée Ouassa, Anna S. Dean, Riccardo Alagna, Guy Damien Adagra, Valeri Ibode, Daniela M. Cirillo, and Jacquemin Kouakou

performed both with and without sample weights (target cluster size divided by the actual number enrolled in cluster) to account for under- and over-enrolment, and the results were compared. For samples with a rifampicin result from both Xpert MTB/RIF and

Open access
European Journal of Microbiology and Immunology
Authors: Souba Diandé, Gisèle Badoum, Adjima Combary, Issaka Zombra, Tandaogo Saouadogo, Léon T. Sawadogo, Bayéma Nébié, Saïdou Gnanou, Adama Zigani, Seydou Mohamed Ouédraogo, Adama Diallo, Seydou Kaboré, and Lassana Sangaré

-Est. Drugs Susceptibility Testing Results The MDR/rifampicin-resistant TB (MDR/RR-TB), pre-XDR-TB, or XDR-TB status for the patients is shown in Table 2. Xpert MTB/RIF detected 41 RR-TB patients – 20 newly treated and 21 PTPs. The overall prevalence

Open access

MA Momeny 2011 Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens J Clin Microbiol

Restricted access

. 14. WHO ( 2011 ) Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System, Policy Statement (WHO/HTM/TB/2011 .4

Restricted access